Multidrug efflux systems endow on bacterial cells the ability to limit the
access of antimicrobial agents to their targets. By actively pumping out an
tibiotic molecules, these systems prevent the intracellular accumulation ne
cessary for antibiotics to exert their lethal activity. Drug efflux appears
to be one of the most widespread antibiotic resistance mechanisms among mi
croorganisms, since it has been demonstrated to occur in many Gram-positive
and Gram-negative bacteria including medically important species like stap
hylococci, streptococci, enterobacteria and opportunistic pathogens like Ps
eudomonas aeruginosa. Efflux pumps can be specific for only one substrate o
r accommodate a more or less wide range of noxious products. Export of stru
cturally unrelated compounds confers a multidrug-resistance phenotype on ba
cterial cells. Therapeutically critical levels of resistance can be achieve
d by overexpression of efflux systems, especially in those species such as
P. aeruginosa which possess a low outer membrane permeability. It is suspec
ted that the dual physiological function of active efflux systems is both t
he secretion of intracellular metabolites and the protection against a vari
ety of harmful substances that the microorganism may encounter in its natur
al environment.